Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Apniben Q
- Development stage
- Unknown
- Lead developer
- Kolon Pharma
- Modality
- Small Molecules
- Administration
- Buccal, Topical
01
Overview
Apniben Q is a mouthwash-type over-the-counter (OTC) medication developed by KOLON Pharma for the treatment of stomatitis (mouth ulcers), gingivitis, glossitis, and pharyngitis. It is formulated as a gargle solution containing diclofenac (specifically diclofenac choline) as its active ingredient. Utilizing a patented Choline Diclofenac Salification (CDS) technology, the formulation enhances the solubility and absorption of diclofenac, allowing it to act directly on the oral mucosa to relieve pain and inflammation without the irritation, burning sensation, or taste issues associated with traditional topical stomatitis treatments. It is free of steroids and alcohol, making it suitable for both adults and children.
- Brand names
- Apniben Q
- Other names
- Apniben Q LiquidApniben Q Solution아프니벤큐아프니벤큐액
02
Targets
PGHS-1 (Prostaglandin G/H Synthase 1)
Beyond the preview
Go deeper on Apniben Q.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Apniben Q.